Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
25 participants
INTERVENTIONAL
2009-12-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management
NCT01829555
Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)
NCT01563887
Health Behavior Intervention for Adults With Type 1 Diabetes
NCT05823142
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
NCT00945659
Type 2 Diabetes and the Brain in Adolescents
NCT03461510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caffeine abstinence
Brief instruction on beginning and maintaining caffeine abstinence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* impaired chronic glucose control (HbA1c \>= 7%)
* daily consumption of 250 mg caffeine or more in coffee, tea, and other caffeinated beverages
Exclusion Criteria
* use of non-diabetes medications that impact glucose metabolism
* medical of psychiatric history that prevents participation or increases risk
* current pregnancy
* current participation in other clinical trials
* deemed unable to comply with the study protocol for other reasons
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duke University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James D Lane, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00011009 (completed)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.